Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No quarterly yet? What's up? Why isn't this a catalyst? Expect lots of debt but rev's should be strong no?
Should have taken your posts more seriously earlier. Live and learn. Lose and move on. I will come back "after" they post FINS in some imaginary future. The people who said they don't mind chasing were right to wait this one out. Not hating. Just telling it as I see it. The company is real. Their products are good. The management sucks.
Thanks MikeCr for your clarity.
GLTA
We have a small cap biotech company here that has a potential breakthrough product in Myocell.
325mm O/S.
Growing revenue stream.
Low overhead.
Positive cash flow.
Multiple new clinic openings (to include Texas) in support of ASCCOE/GACP.
Partnership with ASCCOE = revenue stream.
Texas RTT law 9/01.
Other states will most likely follow Texas.
Federal RTT Law to be signed by POTUS.
Established RMAT guidelines post 9/01 (relevant only if USRM renews their effort to obtain RMAT which I expect them to).
All this for a measly .03 s/p. Crazy.
I spy another small cap biotech that does not have growing revenues. Is not cash positive. Hasn't even completed phase 1/2 trails and is heading for a R/S. This stock trades above .07...:)
LOL
I am not long like you, so I don't know the answer to this question. Has this CEO publicly communicated with its' shareholders in the recent past? A blog on Twitter would be convenient and helpful don't you think?
I said something similar and got banned from their twitter page.
Hold that thought until Monday evening after deadline.
GLTA
Outstanding post.
My only post for the day.
10Q looks great.
Find another OTC with similar revenues, debt structure, o/s, and multiple catalyst that trades under .04..good luck with that.
Don't understand some of the hand-wringing around here.
Revenues are at an all time high.
GACP is taking all the risk for financing the clinics. It is a partnership. Where do you think the 5 mil is most likely going - its pretty obvious.
USRM only needs to focus on the supply/tech side.
Think about the costs associated with building, operating, and maintaining these clinics. USRM's ROI would not exceed 33% imo. I ran a medical practice for decades. It's very expensive. ROI for brick and mortar medical clinics is risky business.
GLTA
Very well said r2g2.
ARYC$
Waiting is easier said than done. I expect s/p to fall and hold if they don't post FINS by 8/15. The closer we get to 8/15 without a filing the riskier the investment becomes. The catalyst here is FINS. ARYC sales has been doing well all along but how can an investor know what's really going on without FINS? Trust is not enough for me.
GLTA
Positive attitude is good I suppose. Just not really feeling it right now.
GLTU
8/15. There is another 2 weeks extension beyond that for late filing. I am not very optimistic at this point that they intend to file anytime soon.
Hope I am wrong.
GLTA
ARYC must become current before any real tangible value can be assigned.
No one knows the financial situation except for ARYC. Until then, we are in the dark.
FINS will tell all.
Will they release them before 8/15?
Said this before Q2, will say it again. USRM will be bought out by GACP/ASCCE. Not sure why people aren't discussing this in greater depth.
Don't you find it a tad unusual that your CEO and CSO are now employed by said company? How long do you think this arrangement will continue before a change occurs? USRM provides the tech/supply side. GACP provides the infrastructure capital. Eventually GACP will want the profit USRM generates.
I recommend people email Tomas asking for more clarification. I did but have NOT received a response as of yesterday. Get proactive with this. Don't sit on the sidelines. Ask QUESTIONS now!
I am limited to one post per day.
GLTA
It's only Monday. They have until next Monday to post FINS or 2 weeks after that with an extension (I doubt they file an extension). It's time for ARYC to poop or get off the pot imo.
Yeah I thought about the "non-timely" Form 12b-25 but I don't see that scenario playing out honestly because the share holders should be notified if that were the case. It would be great news actually but it would also commit them to follow through. I'm not very optimistic about that right now.
Your 75% "bet" scenario for Q3 sounds quite reasonable.
Nice post. Here is a link regarding J&J dumping Capricor stem cell drug:
http://www.biopharmadive.com/news/jj-drops-stem-cell-partner-capricor/446688/
This is particularly interesting: Capricor is changing the indication for their drug (stem cells).
"...Capricor is now pursuing CAP-1002 as a treatment for Duchenne muscular dystrophy."
Why did they give up on treating CHF?
Meanwhile, I believe Mesoblast is still looking for a new partner to help fund their 100 million dollar trials.
Of the three: USRM, Mesoblast, and Capricor, who had the best results from their trails for treating CHF?
What does this say about USRM's competition?
Could J&J be looking at USRM?
My one post for the day..:)
Very interesting Delsurfer.
Thank you very much.
I wish I could help you. It's all speculation. Just like the numbers in their FINS.
ARYC says "...audit completion update..."
Well, is it completed or not?
It's non specific which leaves them wiggle room.
Is it just another progress update or does it mean actual completion?
They could have tweeted after that date stating the audit is COMPLETE.
No mention of becoming current either.
What's next? A tweet saying they applied for an extension?
I will hold till next Friday.
I am beginning to understand why some of the longs are salty.
I hope this all this worry and hand-wringing is for nothing.
GLTA
With Q2 looming...
It's buy buy buy.
Get in while you can.
Then 2 weeks post Q2:
Sell sell sell.
This POS is heading back to .02
This is a scam.
I'm calling red all week.
Blah blah blah.
USRM$
I respect that. The way I see it, the longer they remain not current the greater the potential for the SEC to step in. ARYC has used twitter to promote themselves. We will see if their tweets are legitimate regarding the audit.
I'm not questioning whether they obtained an audit. I'm questioning ARYC's motivation to become current.
What is the point of the audit other than to become current?
Why hasn't ARYC spoken about becoming current as their goal?
Why would anyone believe they are intending to become current beyond 8/14 if they fail to come through by Q2 deadline?
Why would anyone trust ARYC moving forward?
I won't.
GLTA
27 July:
"Arrayit reports audit completion update from top accounting firm Rosenberg Rich Baker RRBB Somerset NJ"
I will wait until 8/14.
GLTA
U.S. Stem Cell/American Stem Cell Centers Of Excellence (GACP)...
Reverse merger possibilities?
GACP already finances USRM to provide support for their (GACP) clinics.
How would a merger benefit GACP?
What about USRM/MYOCELL as a buyout candidate? How could this effect their relationship with GACP?
I think this deserves some attention imo.
GLTA
Has anyone considered the costs associated with having to pay for an audit? It's actually not an audit, it's audit(s)... Multiple years worth which is very cost prohibitive for a small company. I have no reason to doubt the motivation for ARYC to become current. It is my speculation that these costs were the primary factor for the delay in completing the audits (besides complexity and legal issues related to the previous audit).
ARYC must become current. They know this. They are living on borrowed time.
The past mistakes by management created an amazing buying opportunity which is why I am here. Becoming current will be a huge catalyst regardless of the final numbers for these audits imo.
Lets have a green day.
Strong close. Volatility happens. Will probably move up early tomorrow AM IMO.
GLTA
Do your own DD DA
Do our own DD DA
This stock is pretty resilient. I wouldn't be surprised to see it bounce back to .019 tomorrow.
GLTA
In the case of ARYC and my investment, at this time, FINS are that matters to someone like me.
GLTU
I hear you Doc,
But it won't happen. Too risky and unprofessional. ARYC would not have made an effort to tell the public about the audit if it didn't have a meaning beyond. The audit is a means-to-an-end, not fluff, it would be self-destructive otherwise imo.
Can't make that public knowledge. The audit is in preparation for the FINS. The release date for FINS is insider only.
"Dangling the carrot of audit being completed for months..."
They provided updates regarding the audit progress what's wrong with that?
Only recently have the updates focused on completion.
The audit as you know involves going back multiple years which adds complexity.
Complexity adds time.
I assume the audit is done and the 10k's and 10Q are being prepared.
I won't wait forever.
GLTA
I hear you.
GLTU and the rest of the longs here..:)
Well USRM?
I be waitin'
Tick Toc.
"...contracts already in place..."? Contacts more likely, not contracts..yet. I'm sure we will hear once they land their first contract. Shouldn't be long. I think I will jump in today. Looks like LCLP is on the right track now finally.
LOL! BEARS CAN'T STOP Q2. LOL!
BULLISH!!!
ARYC is real.
There are plenty of bears on this board too.
It's best to do your own DD.
Make your own decision.
Don't be penny-wise-pound-foolish..:)
Hold....
GLTU
No not crazy. One step at a time. Q2, Q3, Q4...
Q2 matters to me.